J2KBIO 과거 수익 실적
과거 기준 확인 2/6
J2KBIO has been growing earnings at an average annual rate of 6.7%, while the Biotechs industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 70.3% per year. J2KBIO's return on equity is 3.3%, and it has net margins of 2.8%.
주요 정보
6.7%
수익 성장률
-140.3%
EPS 성장률
| Biotechs 산업 성장 | 11.7% |
| 매출 성장률 | 70.3% |
| 자기자본 수익률 | 3.3% |
| 순이익 | 2.8% |
| 최근 수익 업데이트 | 30 Jun 2024 |
수익 및 비용 분석
J2KBIO 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Jun 24 | 35,922 | 1,009 | 5,429 | 1,537 |
| 31 Mar 24 | 30,848 | -312 | 5,199 | 1,402 |
| 31 Dec 23 | 28,472 | 4,844 | 4,332 | 1,217 |
| 30 Sep 23 | 24,780 | 4,100 | 4,000 | 1,118 |
| 30 Jun 23 | 21,088 | 3,356 | 3,668 | 1,019 |
| 31 Mar 23 | 17,791 | 2,501 | 3,536 | 945 |
| 31 Dec 22 | 16,032 | 2,086 | 3,562 | 878 |
| 31 Dec 21 | 14,219 | 1,623 | 3,012 | 778 |
| 31 Dec 20 | 13,858 | 1,475 | 2,599 | 761 |
양질의 수익: A420570 has high quality earnings.
이익 마진 증가: A420570's current net profit margins (2.8%) are lower than last year (15.9%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: A420570's earnings have grown by 6.7% per year over the past 5 years.
성장 가속화: A420570's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
수익 대 산업: A420570 had negative earnings growth (-69.9%) over the past year, making it difficult to compare to the Biotechs industry average (6.1%).
자기자본 수익률
높은 ROE: A420570's Return on Equity (3.3%) is considered low.